| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1973) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 4B33BGI082 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| SEQUESTERING AGENT | Bile acids sequestering agent | DailyMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hyperlipoproteinemia Type II | 3 | D006938 | ClinicalTrials |
| Lipid Metabolism Disorders | 3 | D052439 | ClinicalTrials |
| Myocardial Infarction | 3 | D009203 | ClinicalTrials |
| Myocardial Ischemia | 3 | D017202 | ClinicalTrials |
| Graves Disease | 3 | D006111 | ClinicalTrials |
| Multiple Sclerosis | 3 | D009103 | ClinicalTrials |
| Kidney Diseases | 1 | D007674 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 11041-12-6 |
| ChEMBL | CHEMBL1201625 |
| FDA SRS | 4B33BGI082 |
| PubChem | 70695641 |
CONTENTS